Department of Gynecology-Obstetrics, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 78, avenue du Général Leclerc, 94275, Le Kremlin-Bicêtre, Cedex, France.
Université Paris-Saclay, UVSQ, CESP, 94807, Villejuif, Inserm, France.
Eur J Pediatr. 2022 Sep;181(9):3483-3490. doi: 10.1007/s00431-022-04532-6. Epub 2022 Jul 4.
Macrosomia in neonates of diabetic women is a risk factor for neonatal hypoglycemia, with an over-risk for asymmetric macrosomia. This study aimed to study the association between anthropometric measurements and hypoglycemia in neonates of mothers treated for gestational diabetes. This is a secondary analysis of the INDAO trial study conducted between May 2012 and November 2016 in 13 French tertiary care university hospitals in 890 pregnant women with gestational diabetes treated with either insulin or glyburide. Neonatal anthropometric measurements were birthweight and weight-length ratio (WLR, defined as birth weight/length). Neonatal hypoglycemia was defined as capillary blood glucose below 36 mg/dL (2 mmol/L) or below 45 mg/dL (2.5 mmol/L) associated with clinical signs after 2 h of life. Their relationships were modeled with logistic regressions using fractional polynomials. Extreme categories of birthweight or WLR adjusted for gestational age at birth and sex were defined as Z-score < -1.28 or > 1.28. These categories were compared to Z-score between -1.28 and 1.28 by estimating odds ratios and confidence intervals for neonatal hypoglycemia. Neonatal hypoglycemia occurred in 9.1% of cases. The relationship between birthweight and WLR Z-scores and neonatal risk of hypoglycemia adjusted for maternal treatment was a U-shaped curve. Adjusted odds ratios for the risk of hypoglycemia were 9.6 (95% CI 3.5, 26.8) and 2.3 (95% CI 1.1, 4.9) for WLR Z-score below -1.28 and above 1.28, respectively, compared with WLR Z-score between -1.28 and 1.28. Conclusion: Birthweight Z-score was associated with the risk of neonatal hypoglycemia in neonates from mothers treated for gestational diabetes. The risk of neonatal hypoglycemia was increased for both extreme birthweight Z-scores, regardless of maternal treatment. Small for gestational age neonates of diabetic mothers require special attention for the risk of neonatal hypoglycemia. What is Known: • Macrosomia in neonates of diabetic women is a risk factor for neonatal hypoglycemia, with an over-risk for asymmetric macrosomia. Few retrospective studies have assessed the risk for neonatal hypoglycemia among small for gestational age neonates born to diabetic mothers. What is New: • The risk of neonatal hypoglycemia among neonates of diabetic mothers increased for both low and high weight-length ratio, regardless of maternal medicinal treatment, gestational age at birth, and sex of the newborn.
患有糖尿病的女性所生新生儿的巨大儿是新生儿低血糖的一个风险因素,其非匀称性巨大儿的风险更高。本研究旨在研究接受过妊娠糖尿病治疗的母亲所生新生儿的人体测量学指标与低血糖之间的关系。这是 2012 年 5 月至 2016 年 11 月期间在法国 13 家三级保健大学医院进行的 INDAO 试验的二次分析,该试验共纳入 890 名接受胰岛素或格列吡嗪治疗的妊娠糖尿病孕妇。新生儿人体测量学指标包括出生体重和体重-长度比(WLR,定义为出生体重/长度)。新生儿低血糖定义为毛细血管血糖低于 36mg/dL(2mmol/L)或低于 45mg/dL(2.5mmol/L),同时伴有生命后 2 小时内的临床体征。使用分数多项式的逻辑回归对其关系进行建模。出生体重或 WLR 的极端类别,经出生时的胎龄和性别调整,定义为 Z 评分 < -1.28 或 > 1.28。通过估计新生儿低血糖的比值比和置信区间,将这些类别与 Z 评分在 -1.28 到 1.28 之间进行比较。新生儿低血糖的发生率为 9.1%。出生体重和 WLR Z 评分与接受母亲治疗的新生儿低血糖风险之间的关系呈 U 形曲线。与 WLR Z 评分在 -1.28 到 1.28 之间相比,WLR Z 评分低于 -1.28 和高于 1.28 时,低血糖风险的调整比值比分别为 9.6(95%CI 3.5,26.8)和 2.3(95%CI 1.1,4.9)。结论:接受过妊娠糖尿病治疗的母亲所生新生儿的出生体重 Z 评分与新生儿低血糖的风险相关。无论母亲的治疗如何,极低和极高出生体重 Z 评分都会增加新生儿低血糖的风险。患有糖尿病的母亲所生小于胎龄儿需要特别注意新生儿低血糖的风险。已知:•患有糖尿病的女性所生新生儿的巨大儿是新生儿低血糖的一个风险因素,其非匀称性巨大儿的风险更高。很少有回顾性研究评估了糖尿病母亲所生小于胎龄儿的新生儿低血糖风险。新发现:• 无论母亲的药物治疗、新生儿的胎龄和性别如何,极低和极高体重-长度比都会增加糖尿病母亲所生新生儿低血糖的风险。